[AsCNP_S11] Symposium-11
The multidimensional approach to metabolic disturbance in schizophrenia

[AsCNP-S11-4] The metabolic protective effect of elevated Orexin-A levels in patients with schizophrenia taking antipsychotics

^○Po-Yu CHEN^{1, 2}, Chin-Kuo CHANG³, Chun-Hsin CHEN^{4, 5}, Mong-Liang LU^{4, 5}, Chih-Chiang CHIU^{2, 4}, Shih-Ku LIN^{2, 4}, Ling-Ling HWANG^{1, 6}, Ming-Chyi HUANG^{1, 2, 4} (1. Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan, 2. Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan, 3. Department of Health and Welfare, University of Taipei, Taipei, Taiwan, 4. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taiwan, 5. Department of Psychiatry, Wan Fang Hospital, Taipei, Taiwan, 6. Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan)